Trio, including former Novartis exec, accused of bribery to the tune of over HK$1.5 million

pharmafile | November 28, 2017 | News story | Manufacturing and Production, Sales and Marketing Novartis, bribery, illegal 

A trio, including a former Senior Medical Representative at Novartis, have been charged over allegedly conspiring to offer and accept bribes of more than HK$1.5 million (US$192,000) in relation to the sale of pharmaceutical products, according to Hong Kong’s Independent Commission Against Corruption.

A joint charge alleges that, between January 2014 and April 2015, 42-year-old Gavin Wong Chun-yin, formerly of Novartis, unlawfully accepted a total of HK$946,750 from 52-year-old Wong Chung-sum, Operator of Hygience Medicine Limited (HML), in exchange for supplying Novartis’ drugs to HML.

A second charge accuses Tsoi Lai-ngan, 58 of Man Hong Dispensary (MHD), of unlawfully giving HK$563,000 to Gavin Wong over a 10-year period from 2005 to 2015, again for supplying Novartis drugs to MHD.

The three accused will appear at the Eastern Magistracy on 30 November.

Matt Fellows

Related Content

Ionis and Novartis partner for CVD treatment programme

Ionis Pharmaceuticals has announced that it has entered into a new collaboration and license agreement …


Novartis acquires Chinook Therapeutics for $3.5bn

Swiss pharmaceutical company Novartis has entered into an agreement and plan of merger with US-based …

Novartis Cosentyx® gains positive CHMP opinion for hidradenitis suppurativa

Basel, April 26, 2023 — Novartis announced today that the Committee for Medicinal Products for Human …

Latest content